BETA

8 Amendments of David MARTIN related to 2014/2206(INI)

Amendment 5 #
Motion for a resolution
Citation 13
– having regard to Council Regulation (EC) No 980/2005 of 27 June 2005 applying a scheme of generalised tariff preferences (GSP Regulation)5 , __________________ 5deleted OJ L 169, 30.6.2005, p. 1.
2015/03/24
Committee: INTA
Amendment 94 #
Motion for a resolution
Paragraph 22
22. Takes the view that the criteria to be applied for the Generalised Scheme of Preferences Plus (GSP+) programme should include the ratification and implementation of the WIPO Trademark Law Treaty, the Geneva Act of the Hague Agreement, the Lisbon Agreement for the Protection of Appellations of Origin and their International Registration, and other IPR-related international agreements;deleted
2015/03/24
Committee: INTA
Amendment 100 #
Motion for a resolution
Paragraph 23
23. Welcomes the work done by the Commission in supporting developing countries wishing to improve their IPR systems, and calls on the Commission to continue and step up these efforts by providing continued appropriate technical assistance in the form of awareness-raising programmes, legislative assistance and training of officials, with consideration given to the levels of development in each country;
2015/03/24
Committee: INTA
Amendment 102 #
Motion for a resolution
Paragraph 24
24. Agrees with the call for a broad response to the complex and multifaceted problem of access to medicines while underlining the importance of a patient- focused approach to IPR in the pharmaceutical sector;
2015/03/24
Committee: INTA
Amendment 117 #
Motion for a resolution
Paragraph 27 – subparagraph 1 (new)
Calls on the Commission and Member States to continue efforts to ensure border measures intended to block the importation of counterfeit medicines do not negatively affect the transit of generic drugs;
2015/03/24
Committee: INTA
Amendment 119 #
Motion for a resolution
Paragraph 28
28. Takes the viewStresses that companies should be encouraged to collaborate in a better way in their competitive environment and to work together with public authorities; calls on the Commission to consider supporting innovative mechanisms such as patent pools to stimulate research while ensuring generic production;
2015/03/24
Committee: INTA
Amendment 122 #
Motion for a resolution
Paragraph 28 a (new)
28a. Insists data exclusivity provisions on pharmaceutical test data is not included in bilateral free trade agreements, in particular in agreements with developing and emerging economies;
2015/03/24
Committee: INTA
Amendment 143 #
Motion for a resolution
Paragraph 39
39. Considers that in negotiations for bilateral free trade agreements priority should be given toshould include chapters on intellectual property, and that the negotiating parties should recognise that the right to conduct a business should take into account respect for IPR;
2015/03/24
Committee: INTA